Skip to main content

Advertisement

Log in

Salivary constituents and acidogenic microbial counts in coronary artery bypass graft patients from baseline to three-years after operation

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Data on saliva in coronary artery bypass graft (CABG) surgery patients are sparse. Understanding salivary parameters, however, may aid clinical decision making. We hypothesized that cardiac surgery might affect patients’ salivary flow rates and buffering, salivary proteins, and microbial counts. A 3-year, open follow-up study was conducted examining salivary flow, its chemical composition, and acidogenic microbial counts in 89 CABG surgery patients. The changes in salivary flow and proteins between baseline and 3-year post-CABG surgery were assessed using paired t-test and, with respect to the median of number of drugs used daily, by use of a nonparametric rank sum test. The results showed no long-term change in salivary flow rates and buffering capacity. With the exception of salivary urea, IgA and IgM concentration, and lysozyme output, the differences in salivary proteins between baseline and 3-year post-CABG were not statistically significant. No difference was observed in saliva values between patients taking drugs below or above the median number of drugs. Acidogenic microbial counts remained the same throughout the study. In conclusion, the salivary flow rates and constituents did not practically change in patients who underwent CABG surgery during the 3-year follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Beck JD, Eke P, Lin D, Madianos P, Couper D, Moss K, Elter J, Heiss G, Offenbacher S (2005) Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 183:342–348

    Article  PubMed  Google Scholar 

  2. Bratthall D, Ericsson D (1996) Tests for assessment of caries risk. In: Thylstrup A, Fejerskov O (eds) Textbook of clinical cariology. Munksgaard, Copenhagen, pp 333–353

    Google Scholar 

  3. Burg MM, Benedetto MC, Soufer R (2003) Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med 65:508–510

    Article  PubMed  Google Scholar 

  4. Choo RE, Huestis MA (2004) Oral fluid as a diagnostic tool. Clin Chem Lab Med 42:1273–1287

    Article  PubMed  Google Scholar 

  5. Dennesen P, van der Ven A, Vlasveld M, Lokker L, Ramsay G, Kessels A, van den Keijbus P, van Nieuw Amerongen A, Veerman E (2003) Inadequate salivary flow and poor oral mucosal status in intubated intensive care unit patients. Crit Care Med 31:781–786

    Article  PubMed  Google Scholar 

  6. Edgar WM, O’Mullane D (1996) Saliva and oral health, 2nd edn. British Dental Association, London, UK

    Google Scholar 

  7. Freudenreich O (2005) Drug-induced sialorrhea. Drugs Today 41:411–418

    Article  PubMed  Google Scholar 

  8. Gabriel M, Zentner A (2005) Sodium dodecyl sulfate agarose gel electrophoresis and electroelution of high molecular weight human salivary mucin. Clin Oral Investig 9:284–286

    Article  PubMed  Google Scholar 

  9. Goldman L (2004) Approach to the patient with possible cardiovascular disease. In: Goldman L, Ausiello D (eds) Cecil textbook of medicine, 22nd edn. Saunders, Philadelphia, pp 242–245

    Google Scholar 

  10. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, Pepys M (1999) C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 12:1733–1740

    Article  Google Scholar 

  11. Hannig M, Dounis E, Henning T, Apitz N, Stosser L (2006) Does irradiation affect the protein composition of saliva? Clin Oral Investig 10:61–65

    Article  PubMed  Google Scholar 

  12. Helenius LM, Meurman JH, Helenius I, Kari K, Hietanen J, Suuronen R, Hallikainen D, Kautiainen H, Leirisalo-Repo M, Lindqvist C (2005) Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand 63:284–293

    Article  PubMed  Google Scholar 

  13. Janket SJ, Qvarnstrom M, Meurman JH, Baird AE, Nuutinen P, Jones JA (2004) Asymptotic dental score and prevalent coronary heart disease. Circulation 109:1095–1100

    Article  PubMed  Google Scholar 

  14. Janket SJ, Meurman JH, Nuutinen P, Qvarnstrom M, Nunn ME, Baird AE, Van Dyke TE, Jones JA (2006) Salivary lysozyme and prevalent coronary heart disease: possible effects of oral health on endothelial dysfunction. Arterioscler Thromb Vasc Biol 26:433–434

    Article  PubMed  Google Scholar 

  15. Janket SJ, Jones J, Sharron R, Miller D, Van Dyke T, Garcia R, Meurman JH (2006) The effects of xerogenic medications on oral mucosa among the veterans dental study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(2):223–230

    Article  PubMed  Google Scholar 

  16. Jokinen JJ, Mustonen PK, Hippelainen MJ, Rehnberg LS, Hartikainen JE (2004) Effects of coronary artery bypass related conduction defects: a 10-year follow-up study. Scand Cardiovasc J 38:235–239

    Article  PubMed  Google Scholar 

  17. Keresztes PA, Merritt SL, Holm K, Penckofer S, Patel M (2003) The coronary artery bypass experience: gender differences. Heart Lung 32:308–319

    Article  PubMed  Google Scholar 

  18. Kullberg BJ, Lashof AM (2002) Epidemiology of opportunistic invasive mycoses. Eur J Med Res 31:183–191

    Google Scholar 

  19. Lehtonen OP, Grahn EM, Stahlberg TH, Laitinen LA (1984) Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infect Immun 43:308–313

    PubMed  Google Scholar 

  20. Mellanen L, Sorsa T, Lahdevirta J, Helenius M, Kari K, Meurman JH (2001) Salivary albumin, total protein, IgA, IgG and IgM concentrations and occurrence of some periodontopathogens in HIV-infected patients: a 2-year follow-up study. J Oral Pathol Med 30:553–559

    Article  PubMed  Google Scholar 

  21. Meurman JH, Rantonen P (1994) Salivary flow rate, buffering capacity, and yeast counts in 187 consecutive adult patients from Kuopio, Finland. Scand J Dent Res 102:229–234

    PubMed  Google Scholar 

  22. Meurman JH, Laine P, Keinänen S, Pyrhönen S, Teerenhovi L, Lindqvist C (1997) Five-year follow-up of saliva in patients treated for lymphomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 83:447–452

    Article  Google Scholar 

  23. Meurman JH, Janket SJ, Qvarnstrom M, Nuutinen P (2003) Dental infections and serum inflammatory markers in patients with and without severe heart disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 96:695–700

    Google Scholar 

  24. Meurman JH, Qvarnström M, Janket S-J, Nuutinen P (2003) Oral health and health behavior in patients referred for open-heart surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 95:300–307

    Google Scholar 

  25. Meurman JH, Rantonen P, Pajukoski H, Sulkava R (2002) Salivary albumin and other constituents and their relation to oral and general health in the elderly. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 94:432–438

    Article  Google Scholar 

  26. Meurman JH, Sanz M, Janket S-J (2004) Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 15:403–413

    Article  PubMed  Google Scholar 

  27. Narhi TO, Meurman JH, Ainamo A (1999) Xerostomia and hyposalivation: causes, consequences and treatment in the elderly. Drugs Aging 15:103–116

    Article  PubMed  Google Scholar 

  28. Oppenheim FG (1970) Preliminary observations on the presence and origin of serum albumin in human saliva. Helv Odontol Acta 14:10–17

    PubMed  Google Scholar 

  29. Pepys M, Gideon M, Hirchfield G, Tennent G, Gallimore R, Kahan M et al (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440:1217–1221

    Article  PubMed  Google Scholar 

  30. Rantonen PJ, Meurman JH (2000) Correlations between total protein, lysozyme, immunoglobulins, amylase, and albumin in stimulated whole saliva during daytime. Acta Odontol Scand 58:160–165

    Article  PubMed  Google Scholar 

  31. Richardson MD, Warnock DW (2003) Fungal infection: diagnosis and management. Blackwell, Oxford, UK, pp 109–128

    Google Scholar 

  32. Rudney JD, Smith QT (1985) Relationships between levels of lysozyme, lactoferrin, salivary peroxidase, and secretory immunoglobulin A in stimulated parotid saliva. Infect Immun 49:469–475

    PubMed  Google Scholar 

  33. Sankar V, Brennan MT, Radfar L, Leakan RA, Pillemer SR (2002) Elevated blood pressure is not related to saliva flow in patients with Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 94:179–183

    Google Scholar 

  34. Shoval I, Kushner JA, Sukhu B, Wood R, Kiss T, Lawrence HP, Tenenbaum HC (2005) The relationship between mouthrinse matrix metalloproteinases (MMP-1, 8, 13) and albumin levels with the degree of oral mucositis in allogeneic stem cell transplant patients. Bone Marrow Transplant 36:33–38

    Article  PubMed  Google Scholar 

  35. Siqueira WL, Bermejo PR, Mustacchi Z, Nicolau J (2005) Buffer capacity, pH, and flow rate in saliva of children aged 2–60 months with Down syndrome. Clin Oral Investig 9:26–29

    Article  PubMed  Google Scholar 

  36. Sreebny LM (1996) Xerostomia: diagnosis, management and clinical complications. In: Edgar WM, O’Mullane DM (eds) Saliva and oral health. British Dental Association, London, pp 43–66

    Google Scholar 

  37. Tenovuo J, Grahn E, Lehtonen OP, Hyyppa T, Karhuvaara L, Vilja P (1987) Antimicrobial factors in saliva: ontogeny and relation to oral health. J Dent Res 66:475–479

    PubMed  Google Scholar 

  38. Webster D (1977) The immediate reaction between bromcresol green and serum as a measure of albumin content. Clin Chem 23:663–665

    PubMed  Google Scholar 

Download references

Acknowledgements

JHM is supported by grant TYH 3245 by Helsinki University Central Hospital, Helsinki, Finland and Ulf Nilsonne Foundation (SalusAnsvar Prize), Stockholm, Sweden, and by the Päivikki and Sakari Sohlberg Foundation, Helsinki, Finland. SJK is funded by The National Scientist Development Grant from The American Heart Association (# 0635351N).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jukka H. Meurman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qvarnström, M., Janket, SJ., Nuutinen, P. et al. Salivary constituents and acidogenic microbial counts in coronary artery bypass graft patients from baseline to three-years after operation. Clin Oral Invest 11, 217–223 (2007). https://doi.org/10.1007/s00784-007-0114-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-007-0114-3

Keywords

Navigation